143 related articles for article (PubMed ID: 36233527)
41. [Efficacy of electroacupuncture nerve stimulation therapy for interstitial cystitis/bladder pain syndrome].
Lv TT; Lv JW; Wang SY; Jiang C; Gu YJ; Liu HR
Zhongguo Zhen Jiu; 2019 May; 39(5):467-72. PubMed ID: 31099215
[TBL] [Abstract][Full Text] [Related]
42. Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis/bladder pain syndrome: A pilot study.
El Hefnawy AS; Hasan MAA; El Sawy E; Abdel-Razik M; El-Tabey N
Curr Urol; 2024 Mar; 18(1):49-54. PubMed ID: 38505153
[TBL] [Abstract][Full Text] [Related]
43. Metabolic syndrome in women with and without interstitial cystitis/bladder pain syndrome.
Peng L; Di XP; He SX; Zeng X; Shen H; Zhu HL; Luo DY
Int Urogynecol J; 2021 May; 32(5):1299-1306. PubMed ID: 33215272
[TBL] [Abstract][Full Text] [Related]
44. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
45. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
[TBL] [Abstract][Full Text] [Related]
46. Clinical manifestations and results of cystoscopy in women with interstitial cystitis/bladder pain syndrome.
Sholan R
North Clin Istanb; 2020; 7(5):417-424. PubMed ID: 33163875
[TBL] [Abstract][Full Text] [Related]
47. Effect of low-dose triple therapy using gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug for overactive bladder symptoms in patients with bladder pain syndrome.
Kwon WA; Ahn SH; Oh TH; Lee JW; Han DY; Jeong HJ
Int Neurourol J; 2013 Jun; 17(2):78-82. PubMed ID: 23869272
[TBL] [Abstract][Full Text] [Related]
48. The water avoidance stress induces bladder pain due to a prolonged alpha1A adrenoceptor stimulation.
Matos R; Serrão P; Rodriguez L; Birder LA; Cruz F; Charrua A
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):839-844. PubMed ID: 28569366
[TBL] [Abstract][Full Text] [Related]
49. Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis/bladder pain syndrome: a case series (UNICORN-2 study).
Okui N; Okui M; Vizintin Z
Climacteric; 2020; 23(sup1):S14-S17. PubMed ID: 33124452
[No Abstract] [Full Text] [Related]
50. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
51. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Kuo YC; Kuo HC
Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
[TBL] [Abstract][Full Text] [Related]
52. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion.
Kim HJ; Lee JS; Cho WJ; Lee HS; Lee HN; You HW; Jung W; Lee KS
Int J Urol; 2014 Apr; 21 Suppl 1():69-73. PubMed ID: 24807503
[TBL] [Abstract][Full Text] [Related]
54. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
[TBL] [Abstract][Full Text] [Related]
55. Modified Botulinum Toxin Type A Injections Improve Symptoms Associated With Interstitial Cystitis/Bladder Pain Syndrome in Women: A Retrospective Cohort Study.
Wang Y; Zheng J; Li Z; Jiang Y; Yu J; Li S; Chen X
Urology; 2024 May; ():. PubMed ID: 38710455
[TBL] [Abstract][Full Text] [Related]
56. Clinical Efficacy of 1-Year Intensive Systematic Dietary Manipulation as Complementary and Alternative Medicine Therapies on Female Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Oh-Oka H
Urology; 2017 Aug; 106():50-54. PubMed ID: 28435032
[TBL] [Abstract][Full Text] [Related]
57. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
58. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome.
Yu WR; Peng TC; Yeh HL; Kuo HC
Neurourol Urodyn; 2019 Aug; 38(6):1602-1610. PubMed ID: 31059599
[TBL] [Abstract][Full Text] [Related]
59. Effects of a Short Course of Oral Prednisolone in Patients with Bladder Pain Syndrome with Fluctuating, Worsening Pain despite Low-Dose Triple Therapy.
Jeong HJ
Int Neurourol J; 2012 Dec; 16(4):175-80. PubMed ID: 23346483
[TBL] [Abstract][Full Text] [Related]
60. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
